Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Circulation
|
May 22, 2002
Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice
Jacob George, Arnon Afek, Pnina Keren, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 11, 2003
The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model
Esther Shohami, Ido Yatsiv, Alexander Alexandrovich, et al.
Oncotarget
|
July 11, 2012
Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton
Efrat Mashiach-Farkash, Roni Rak, Galit Elad-Sfadia, et al.
Plos One
|
August 12, 2010
H-Ras nanocluster stability regulates the magnitude of MAPK signal output
Barak Rotblat, Liron Belanis, Hong Liang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 13, 2003
Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor
Jacob George, Jessica Sack, Iris Barshack, et al.
Stem Cell Reports
|
February 20, 2018
RAS Regulates the Transition from Naive to Primed Pluripotent Stem Cells
Anna Altshuler, Mila Verbuk, Swarnabh Bhattacharya, et al.
Cancer Research
|
January 25, 2011
Oncogenic synergism between ErbB1, nucleolin, and mutant Ras
Keren Farin, Sari Schokoroy, Roni Haklai, et al.
Plos One
|
March 30, 2011
The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy
Yoram Nevo, Shlomit Aga-Mizrachi, Edva Elmakayes, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Circulation
|
May 22, 2002
Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice
Jacob George, Arnon Afek, Pnina Keren, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 11, 2003
The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model
Esther Shohami, Ido Yatsiv, Alexander Alexandrovich, et al.
Oncotarget
|
July 11, 2012
Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton
Efrat Mashiach-Farkash, Roni Rak, Galit Elad-Sfadia, et al.
Plos One
|
August 12, 2010
H-Ras nanocluster stability regulates the magnitude of MAPK signal output
Barak Rotblat, Liron Belanis, Hong Liang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 13, 2003
Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor
Jacob George, Jessica Sack, Iris Barshack, et al.
Stem Cell Reports
|
February 20, 2018
RAS Regulates the Transition from Naive to Primed Pluripotent Stem Cells
Anna Altshuler, Mila Verbuk, Swarnabh Bhattacharya, et al.
Cancer Research
|
January 25, 2011
Oncogenic synergism between ErbB1, nucleolin, and mutant Ras
Keren Farin, Sari Schokoroy, Roni Haklai, et al.
Plos One
|
March 30, 2011
The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy
Yoram Nevo, Shlomit Aga-Mizrachi, Edva Elmakayes, et al.
Page
of 3